| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Kozarich John W is a Director at LGNYZ, with reported holdings spanning 3 companies. Recent filings cover 0 purchases and 80 sales. Those positions are worth an estimated $2.9M at current prices.
Our model assigns Kozarich John W a middling insider score of 55/100, based on 10 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -19.2%.
Kozarich John W's largest disclosed position is in LGND as Director, worth about $2.9M. The recent filings there lean toward selling, a net 50,230 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | LGND Ligand Pharmaceuticals Incorporated | Director | Sale+OE10b5-1 | 2,501 | $225.14 | $563,079.63 | -5.6% | +30.5% | - | |
| Apr 1, 2026 | LGND Ligand Pharmaceuticals Incorporated | Director | Sell10b5-1 | 467 | $202.23 | $94,440.09 | -1.1% | +58.3% | - | |
| Mar 2, 2026 | LGND Ligand Pharmaceuticals Incorporated | Director | Sell10b5-1 | 467 | $200.50 | $93,632.37 | -1.1% | +13.4% | - | |
| Feb 2, 2026 | LGND Ligand Pharmaceuticals Incorporated | Director | Sell10b5-1 | 467 | $195.91 | $91,490.04 | -1.1% | +15.4% | - | |
| Jan 2, 2026 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 467 | $189.58 | $88,532.49 | -1.1% | +5.0% | - | |
| Dec 1, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 467 | $195.84 | $91,456.89 | -1.0% | +2.8% | - | |
| Nov 3, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 467 | $191.05 | $89,219.01 | -1.0% | +3.5% | - | |
| Oct 1, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 467 | $179.44 | $83,800.34 | -1.0% | +6.2% | +69.1% | |
| Sep 2, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 467 | $162.26 | $75,774.85 | -1.0% | +20.3% | +75.2% | |
| Aug 1, 2025 | LGND Ligand Pharmaceuticals Inc | Director | Sell10b5-1 | 467 | $131.88 | $61,585.86 | -1.0% | +40.9% | +116.7% |